Please use this identifier to cite or link to this item:
https://hdl.handle.net/11499/10285
Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Cevahir, Nural | - |
dc.contributor.author | Gürbüz, Melahat | - |
dc.contributor.author | Demir, Melek | - |
dc.contributor.author | Kaleli, İlknur | - |
dc.date.accessioned | 2019-08-16T13:15:08Z | |
dc.date.available | 2019-08-16T13:15:08Z | |
dc.date.issued | 2015 | - |
dc.identifier.issn | 0023-5776 | - |
dc.identifier.uri | https://hdl.handle.net/11499/10285 | - |
dc.description.abstract | Objectives: To investigate the prevalence of PER-1, PER-2, GES, IMP-1, VIM-2, OXA-23, and OXA-24 type beta-lactamases in carbapenem-resistant Acinetobacter baumannii isolates, in view of the fact that Beta-lactamase production is the most important mechanism of acquired beta-lactam resistance in Gram-negative pathogens. Design: Experimental study Setting: Department of Medical Microbiology, School of Medicine, Pamukkale University, Denizli, Turkey Subjects: From January 2009 to December 2009, a total of 98 carbapenem-resistant A. baumannii bacteria were isolated from patients. Intervention: In-house PCR was performed for the detection of PER-1, PER-2, GES, IMP-1, VIM-2, OXA-23, and OXA-24 beta-lactamase genes in those clinical carbapenem-resistant A. baumannii isolates. Main Outcome Measure: Prevalence rate of beta-lactamase genes in carbapenem-resistant A. baumannii isolates Results: GES beta-lactamase was found in 59 isolates (60.20%). PER-1 was found in eight isolates (8.16%). IMP-1 was found in five isolates (5.10%). OXA-24 was detected in two isolates (2.04%). No isolate possessed VIM-2, PER-2, or OXA-23 beta-lactamase genes. Conclusion: This study indicates that the GES type beta-lactamases are the most prevalent among carbapenem-resistant A. baumannii isolates in our hospital. Screening for beta-lactamases and strict infection control for these isolates will help prevent further spread of resistance. © 2015, kuwait Medical Association. All rights reserved. | en_US |
dc.language.iso | en | en_US |
dc.publisher | Kuwait Medical Association | en_US |
dc.relation.ispartof | Kuwait Medical Journal | en_US |
dc.rights | info:eu-repo/semantics/closedAccess | en_US |
dc.subject | A. baumannii isolate | en_US |
dc.subject | Beta-lactamase genes | en_US |
dc.subject | Carbapenem resistance | en_US |
dc.subject | amikacin | en_US |
dc.subject | beta lactamase | en_US |
dc.subject | carbapenem | en_US |
dc.subject | cefepime | en_US |
dc.subject | cefotaxime | en_US |
dc.subject | ceftazidime | en_US |
dc.subject | ceftriaxone | en_US |
dc.subject | ciprofloxacin | en_US |
dc.subject | colistin | en_US |
dc.subject | cotrimoxazole | en_US |
dc.subject | gentamicin | en_US |
dc.subject | GES type beta lactamase | en_US |
dc.subject | imipenem | en_US |
dc.subject | IMP 1 type beta lactamase | en_US |
dc.subject | meropenem | en_US |
dc.subject | OXA 23 type beta lactamase | en_US |
dc.subject | OXA 24 type beta lactamase | en_US |
dc.subject | PER 1 type beta lactamase | en_US |
dc.subject | PER 2 type beta lactamase | en_US |
dc.subject | piperacillin | en_US |
dc.subject | piperacillin plus tazobactam | en_US |
dc.subject | sultamicillin | en_US |
dc.subject | tetracycline | en_US |
dc.subject | tobramycin | en_US |
dc.subject | unclassified drug | en_US |
dc.subject | VIM 2 type beta lactamase | en_US |
dc.subject | Acinetobacter baumannii | en_US |
dc.subject | antibiotic resistance | en_US |
dc.subject | antibiotic sensitivity | en_US |
dc.subject | Article | en_US |
dc.subject | bacterium isolate | en_US |
dc.subject | carbapenem resistant Acinetobacter baumannii | en_US |
dc.subject | controlled study | en_US |
dc.subject | disk diffusion | en_US |
dc.subject | experimental study | en_US |
dc.subject | gene amplification | en_US |
dc.subject | gene identification | en_US |
dc.subject | genetic variability | en_US |
dc.subject | infection control | en_US |
dc.subject | nonhuman | en_US |
dc.subject | polymerase chain reaction | en_US |
dc.subject | prevalence | en_US |
dc.title | Investigation of Beta-Lactamases in carbapenem-resistant A. Baumannii isolates | en_US |
dc.type | Article | en_US |
dc.identifier.volume | 47 | en_US |
dc.identifier.issue | 1 | en_US |
dc.identifier.startpage | 24 | |
dc.identifier.startpage | 24 | en_US |
dc.identifier.endpage | 29 | en_US |
dc.relation.publicationcategory | Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı | en_US |
dc.identifier.scopus | 2-s2.0-84924940179 | en_US |
dc.identifier.wos | WOS:000351331100005 | en_US |
dc.identifier.scopusquality | Q4 | - |
dc.owner | Pamukkale University | - |
item.openairecristype | http://purl.org/coar/resource_type/c_18cf | - |
item.grantfulltext | none | - |
item.languageiso639-1 | en | - |
item.openairetype | Article | - |
item.fulltext | No Fulltext | - |
item.cerifentitytype | Publications | - |
crisitem.author.dept | 14.03. Basic Medical Sciences | - |
crisitem.author.dept | 14.03. Basic Medical Sciences | - |
crisitem.author.dept | 14.03. Basic Medical Sciences | - |
crisitem.author.dept | 14.03. Basic Medical Sciences | - |
Appears in Collections: | Scopus İndeksli Yayınlar Koleksiyonu / Scopus Indexed Publications Collection Tıp Fakültesi Koleksiyonu WoS İndeksli Yayınlar Koleksiyonu / WoS Indexed Publications Collection |
CORE Recommender
Items in GCRIS Repository are protected by copyright, with all rights reserved, unless otherwise indicated.